The Potential of Selenium-Based Therapies for Ocular Oxidative Stress.

antioxidant glutathione peroxidase ocular conditions oxidative stress selenium selenoprotein

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
08 May 2024
Historique:
received: 27 03 2024
revised: 26 04 2024
accepted: 01 05 2024
medline: 25 5 2024
pubmed: 25 5 2024
entrez: 25 5 2024
Statut: epublish

Résumé

Oxidative stress plays a critical role in the development of chronic ocular conditions including cataracts, age-related macular degeneration, and diabetic retinopathy. There is a need to explore the potential of topical antioxidants to slow the progression of those conditions by mediating oxidative stress and maintaining ocular health. Selenium has attracted considerable attention because it is a component of selenoproteins and antioxidant enzymes. The application of selenium to a patient can increase selenoprotein expression, counteracting the effect of reactive oxygen species by increasing the presence of antioxidant enzymes, and thus slowing the progression of chronic ocular disorders. Oxidative stress effects at the biomolecular level for prevalent ocular conditions are described in this review along with some of the known defensive mechanisms, with a focus on selenoproteins. The importance of selenium in the eye is described, along with a discussion of selenium studies and uses. Selenium's antioxidant and anti-inflammatory qualities may prevent or delay eye diseases. Recent breakthroughs in drug delivery methods and nanotechnology for selenium-based ocular medication delivery are enumerated. Different types of selenium may be employed in formulations aimed at managing ocular oxidative stress conditions.

Identifiants

pubmed: 38794293
pii: pharmaceutics16050631
doi: 10.3390/pharmaceutics16050631
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Auteurs

Lulwah Al-Bassam (L)

UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK.

Gemma C Shearman (GC)

School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Penrhyn Rd, Kingston upon Thames KT1 2EE, UK.

Steve Brocchini (S)

UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK.

Raid G Alany (RG)

School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Penrhyn Rd, Kingston upon Thames KT1 2EE, UK.
School of Pharmacy, The University of Auckland, Auckland 1142, New Zealand.

Gareth R Williams (GR)

UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK.

Classifications MeSH